Clinical Trial Update: ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on ERA-923 for metastatic breast cancer in postmenopausal women; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ERA-923

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN